Evidence has accumulated indicating that the fibrinoid deposits found in histopathologic material in certain human diseases-for example, acute lupus erythematosus and polyarteritis-may be derived, at least in part, from fibrinogen, fibrin, or a closely related protein (1, 2) . Studies of the conditions under which similar deposits are laid down in the blood vessels of rabbits during the generalized Shwartzman reaction (3, 4) and after injection of gram-negative bacterial endotoxin in combination with acidic polymers of large molecular size (5, 6), have provided an experimental model for studying the origin of these deposits. In the rabbit a direct correlation between the disappearance of fibrinogen from the circulating blood and the appearance of fibrinoid within the glomerular blood vessels was observed, and the suggestion was made that endotoxin produced an increase in the in vivo precipitability of fibrinogen by acidic polymers (7, 8) . It was shown that within less than one hour after an intravenous injection of endotoxin, a change in the stability of fibrinogen occurred which was manifested by the cold-insolubility of this protein in the presence of heparin (7, 9). It seemed possible that this heparin-precipitable form of fibrinogen might represent, in the rabbit, a precursor of fibrinoid, and a study of the occurrence of a similar cold-insoluble, heparin-precipitable component in human plasma was therefore undertaken.
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Data will be presented which 1) describe the essential features necessary for the precipitation reaction to occur, 2) define the solubility in terms of pH, ionic strength, and a requirement for specific cations, and 3) establish a close relationship between the fraction and fibrinogen. The nature of the heparin-fibrinogen combination and its possible relationships to previously described fibrinogen fractions are discussed. Preliminary accounts of these observations have been presented elsewhere (10, 11) . The effect of ionic strength and pH on HPF solubility The effect of ionic strength and pH alterations of heparinized plasma on precipitate yield is illustrated by a typical experiment shown in Table  III . In these experiments various concentrations of NaCl were added to plasma prior to chilling. The yield of HPF decreased progressively with increasing ionic strength.
MATERIALS AND METHODS

Heparin-precipitable fraction (HPF
The desired final pH of heparinized plasma was obtained by stepwise addition of 0.1 N hydrochloric acid. In an illustrative experiment recorded in Table IV , final pH values at room temperature were 6.7, 7.0, 7.5, and 7.9. Maximum precipitate yield from plasma after chilling to 20 C for 18 hours was obtained at pH 7.0.
The effect of varying ionic strength at several pH values on the solubility of the isolated fraction was then examined. In the experiment summarized in Table VI , addition of calcium chloride to a final concentration between 0.004 and 0.005 millimol per ml. resulted in a yield equivalent to that obtained from the original heparinized plasma, within the limits of experimental error. Calcium added to the cation-depleted plasma to 0.01 millimol per ml. resulted in a larger yield of precipitate than that occurring in the untreated plasma. The addition of magnesium ions to depleted plasma resulted in similar increases in precipitation.
Evidence for a relationship between the heparinprecipitable fraction and fibrinogen In previous studies evidence that the heparinprecipitable fraction appearing in the plasma of endotoxin-treated rabbits was closely associated with or related to fibrinogen, depended upon a) absence from serum, b) partial clottability by thrombin, c) similar electrophoretic mobility, and d) disappearance in vivo along with circulating fibrinogen when high molecular weight acidic polymers having the property of precipitating fibrinogen in vitro were administered to endotoxintreated rabbits (7, 9) . Inasmuch as the fraction was not demonstrable in normal rabbit plasma, appearing only after injection of bacterial endotoxin, it was concluded that the fraction differed qualitatively from fibrinogen (7) .
Evidence that the heparin-precipitable fraction from humans resembles fibrinogen has been sought. As indicated in Table I solved fraction determined in the analytical ultracentrifuge at 20°C shows two peaks. A typical pattern is shown in Figure 2 . The slower mooving peak, accounting for approximately 80 per cent of the protein in most patients studied has a sedimentation constant (S20,v) ranging between 7.9 and 8.3. This value is similar to that reported for human fibrinogen (17 
DISCUSSION
These experiments define some of the attributes of a component of human plasma characterized by a low solubility in the presence of heparin or related acidic polymers. Evidence has been presented that the plasma component is present, but soluble in freshly drawn decalcified plasma. Addition of heparin decreases the solubility of the fraction so that it is demonstrable simply by chilling to 2°C. The solubility of the isolated precipitable fraction is lowest in the presence of bivalent cations, at low temperature, low pH, and low ionic strength. In its solubility properties, absence from serum, clottability, electrophoretic mobility, and sedimentation characteristics, human HPF appears, as in the case of rabbit HPF (7), to be very similar to fibrinogen. On the other hand, experiments in which heparin was added to "purified" fibrinogen preparations indicate that only a small percentage of the protein in fibrinogen preparations used for clinical purposes is insoluble at low temperatures in the presence of heparin.
Considerable evidence has accumulated (18) (19) (20) (21) (22) indicating that certain acidic polymers have a strong affinity for fibrinogen and the beta lipoproteins, less for other proteins, and that the complexes apparently formed between them exhibit solubility properties and resistance to denaturation not characteristic of the native protein.
Astrup and Piper (18) apparently were first to recognize and study such complexes systematically. They found that cellulose trisulfuric acid, polyanethol sulfonate, and similar high molecular weight compounds, precipitated fibrinogen from citrated plasma or purified fibrinogen preparations at room temperature. The effects of polymer concentration, pH, ionic strength, and magnesium ions on this reaction were similar to those described above for cold-precipitation from heparinized plasma. They reported no precipitation occurring with chitin sulfate or heparin; however, their experiments were conducted at room temperature. Experiments not included in this paper confirm their observations with polyanethol sulfonate.
Ricketts (19) , Walton (20, 21) , and others (22) more recently have examined the interaction between dextran sulfates of varying molecular weight and fibrinogen. These studies have shown that dextran sulfates of intrinsic viscosities 0.24 to 0.4 added to fibrinogen solutions result in precipitation at 40 C but not at 370 C. Dextran sulfates of higher intrinsic viscosity and presumably higher molecular weight, however, precipitated fibrinogen at 370 C. Recently Kerby (23) reported that chondroitin sulfate added to citrated plasma from patients with inflammatory disease resulted in cold-precipitation of a polysaccharideprotein complex.
These various items of evidence indicating the affinity of high molecular weight sulfated polysaccharides for fibrinogen permit speculation on a possible physiological role of the protein which precipitates with heparin, as HPF, i.e., in the removal from the circulation of high molecular weight polysaccharides that arise from damage to ground substance. Such protein-polysaccharide complexes, if aggregated into macromolecular particles of sufficient size, would be immediately subject to removal by the cells of the reticuloendothelial system. Should the rate of complex formation exceed the capacity for removal by the R. E. system, deposition of the complexes, as fibrinoid, might occur. The experimental data available (24) (25) (26) lend support to this possibility.
Some properties of HPF closely resemble those of Fraction I-1, a cold-insoluble plasma component, described by Morrison, Edsall, and Miller (27) , and more recently investigated by Edsall, Gilbert, and Scheraga (28 (29) studied a component designated "contractinogen" obtained from the plasma of pregnant or acutely ill patients by precipitation with 16% per cent saturated ammonium sulfate. Contractinogen was reversibly cold-insoluble and showed an unusual propensity to clot spontaneously, and then retract markedly. This protein, rather than the more soluble clottable fractions, was thought to be responsible for aggregation and settling of red blood cells in the determination of the erythrocyte sedimentation rate.
Another fibrinogen component, studied extensively by Lyons (30) and termed "fibrinogen B," has been characterized by its insolubility when combined with certain naphthoquinone derivatives. "Fibrinogen B" was reported to be present in significant amounts in a varied assortment of diseases, particularly infectious and thrombotic states, but not in normal individuals.
Recently, Korst and Kratochvil (31) reported a case of pulmonary malignancy and multiple thromboses associated with "cryofibrinogenemia." A component from this patient's plasma was found to be reversibly precipitable at low temperatures, clottable, rouleaux-promoting and betanaphtholprecipitable. Heparin augmented cold-precipitation of the component from citrated plasma (32) . The sedimentation value for the major component of this fraction (Sm = 7.9) resembled fibrinogen (17); a minor component had an Sm value of approximately 12 (estimated from published data). This "abnormal" fibrinogen resembles HPF in several ways, then, but apparently does not require the presence of heparin to precipitate at low temperatures. However, the possibility that an endogenous heparin-like component may have been present in their patient's circulation was not excluded. Where data are available, then, the close similarity of each of these "abnormal" fibrinogen fractions is striking.
Morrison (29) has suggested that contractinogen represents a qualitative alteration of fibrinogen, perhaps partial polymerization, occurring as a result of disease. A similar hypothesis was proposed in relation to the occurrence of HPF in experimental animals following endotoxin administration (7, 8) . HPF in humans might also represent a polymer formed during the conversion of fibrinogen to fibrin, resembling those studied by Apitz (33) , more recently by Donnelly, Laskowski, Notley, and Scheraga (34) and Casassa (35) .
On the other hand, the possibility is not excluded that this group of fractions related to or associated with fibrinogen might represent a segment of the spectrum of fibrinogen-like proteins, each of which differs slightly from "pure" clottable protein, in solubility, and possibly in physiological function. Current studies of the relative turnover rates of this more insoluble fraction compared with the clottable fraction may illuminate this point.
SUMMARY AND CONCLUSION
Some of the physical and chemical properties of a fraction of human plasma which is characterized by cold-insolubility in the presence of heparin have been described. The data indicate that the fraction is a fibrinogen-like protein loosely combined with heparin, the resultant complex having altered solubility properties. Solubility of the fraction was found to be favored by increasing ionic strength, elevated temperature, alkaline pH, and the absence of calcium or magnesium ions. The amount of cold-insoluble fraction obtained from a given plasma is a function of the heparin concentration. Evidence was obtained that the heparin-precipitable fraction is closely related to or associated with fibrinogen in that it is partially clottable, has similar mobility on electrophoresis, and is absent from serum. In the ultracentrifuge two components were found, the major fraction resembling fibrinogen, the minor component resembling the cold-insoluble, non-clotting component of Fraction I-1.
The possible relationships between heparinprecipitable fraction and previously reported fibrinogen-like proteins are discussed, and available data bearing on the possible nature and origin of the fraction are reviewed.
